Driver mutations alter cellular behavior in ways that can support growth or survival, giving affected cells a selective advantage. Passenger mutations accompany this expansion but do not provide the same benefit. Distinguishing these categories helps cancer researchers identify alterations most likely to contribute directly to tumor development rather than treating every detected sequence change as equally important.
A sequence change does not have a uniform consequence across all cells. Its effect depends on the affected gene, the type of DNA alteration, and the surrounding cellular context. These factors help determine whether a mutation changes cell behavior, remains harmless, or contributes to clonal expansion, making biological interpretation essential when analyzing tumor genomes.
When DNA damage or replication errors escape repair, they can accumulate as permanent sequence changes. A defective repair pathway may therefore leave a recognizable pattern across the genome, known as a mutational signature. Studying these patterns can help researchers infer contributing biological processes and connect particular mutation profiles with mechanisms that shaped a cancer.
Repeated alterations can create subpopulations of cells with different growth or survival properties. Cells carrying advantageous changes may expand more successfully, causing the tumor to acquire a history of successive clonal changes. Reconstructing these patterns allows cancer researchers to examine how tumors develop over time and separate influential alterations from changes that simply accumulated during expansion.
Researchers sequence tumor genomes and examine the resulting DNA changes for their locations, types, and broader patterns. They then assess whether groups of alterations form mutational signatures or correspond to genes associated with altered cell behavior. This workflow supports interpretation of the tumor’s mutation history and helps connect observed changes with possible repair defects or exposures.
Analysis of somatic mutations can help identify cancer-related alterations, distinguish them from harmless passenger changes, and reconstruct tumor evolution. Mutational signatures may provide clues about contributing exposures or defective repair pathways. Together, these findings can support cancer diagnosis, prognosis assessment, and the development of targeted treatment strategies based on the tumor’s molecular features.